The Weizmann Institute is dedicated to encouraging the development of science and scientific research for the benefits of all humanity. Each year the institute awards the award to an individual that it believes exemplifies their mission. For 2017, the institute has given the award to Jeff Aronin, the chairman and CEO of Paragon Biosciences.
Jeff Aronin has almost 20 years of experience in developing biomedical research companies. He employs a philosophy of patients first when he manages the firms he is involved with. He understands that there can be no company success without healing people first. He used his expertise in strategy, finance, and marketing to bring Ovation Pharmaceuticals, Inc. from infancy to a $900 million acquisition in 2009. During the acquisition process, Jeff Aronin also served as the CEO of Lundbeck Inc., the parent company.
Jeff Aronin is currently the CEO of Paragon Biosciences. He is also the CEO of Paragon Pharmaceutical Capital, a life sciences investment company which holds a portfolio that includes SureGene and Decade Pharmaceuticals. He approaches his work with enthusiasm and dedication which is unequaled in his field.
Family and Community
The key to Jeff Aronin’s success would not be complete without mentioning his involvement in both his family and his community. Without the inspiration and the influence of his wife Lisa and his three daughters, he would not have the motivation to be so involved in his numerous business projects and community activities. Jeff Aronin is also a board member of the Museum of Science and Industry, the Economic Club of Chicago, and Discover Financial Services. This is in addition to his numerous mentorship projects.
It is because of his dynamism and his ability to multitask in both business and philanthropic endeavors, all while finding a balance in his home life, that the Weizmann Institute has awarded Jeff Aronin the Weizmann Institute Leadership Award.